Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy

BACKGROUND: Neuropathy is a dose-limiting side effect of many chemotherapeutics, including bortezomib. The mechanisms underlying this condition are not fully elucidated even if a contribution of neuroinflammation was suggested. Here, we investigated the role of a chemokine family, the prokineticins...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Neuroinflammation
Main Authors: Moschetti, Giorgia, Amodeo, Giada, Maftei, Daniela, Lattanzi, Roberta, Procacci, Patrizia, Sartori, Patrizia, Balboni, Gianfranco, Onnis, Valentina, Conte, Vincenzo, Panerai, Alberto, Sacerdote, Paola, Franchi, Silvia
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2019
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6471808/
https://ncbi.nlm.nih.gov/pubmed/30995914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-019-1461-0
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים